Delft Instruments appoints Managing Director for subsidiary Nucletron

October 26 2005  

Veenendaal, The Netherlands,-  Delft Instruments appoints Mr. David Imperiali as Managing Director of its subsidiary Nucletron.


Responsible for the entire Nucletron Business Unit and reporting directly to the Executive Board of Delft Instruments, David Imperiali succeeds Mr. Bert de Groot, CEO of Delft Instruments, who handed over his temporary assignment per 15 October 2005 as Nucletron’s interim Managing Director.


David is an entrepreneurial senior healthcare executive with a broad scope of experience and a strong international network, who has spent most of his career in Medical Technology. From 1996 to 2001 he led the international business of Allegiance Healthcare, taking it through spin-off by one parent company into a publicly listed company, and finally a merger with Cardinal Health. From 2001 to his appointment at Nucletron, he has managed a portfolio of activities including fee based consulting, supervisory board positions and investing in healthcare start-up companies. In 1974 David obtained a BA in Mathematics & Philosophy from the University of Liverpool, after which he spent six years as a Teacher of Mathematics. He subsequently chose a business career, and enrolled in one of England’s first MBA programs at Manchester Business School & New York University. He graduated in 1982 and started his career in the healthcare industry within the same year.



About Nucletron B.V.

Nucletron is a global leader in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in treatment planning systems, brachytherapy, simulation, integrated software solutions for oncology, and comprehensive support and professional education and services. The company has over 20 offices worldwide, including its corporate headquarters in Veenendaal, the Netherlands. For more information on Nucletron, please visit: http://www.nucletron.com/.


Nucletron B.V. is a subsidiary of Delft Instruments. Delft Instruments is the holding company of an international group of companies, which hold a leading position in their respective markets with high quality, high technology products and services. Delft Instruments is active through wholly owned subsidiaries in more than 30 countries worldwide, employs approximately 1,000 people and reported turnover of EUR 261.6 million in 2004. For more information on Delft Instruments, please visit: http://www.delftinstruments.com/. 




For further information: